Literature DB >> 4702478

An electromyographic study of recurrent laryngeal nerve conduction and its clinical applications.

J P Atkins.   

Abstract

Mesh：

Year:  1973        PMID： 4702478     DOI： 10.1288/00005537-197305000-00015

Source DB:  PubMed          Journal:  Laryngoscope        ISSN： 0023-852X            Impact factor:   3.325


× No keyword cloud information.
  6 in total

1.  Distal spinal and bulbar muscular atrophy caused by dynactin mutation.

Authors:  Imke Puls; Shin J Oh; Charlotte J Sumner; Karen E Wallace; Mary Kay Floeter; Eric A Mann; William R Kennedy; Gwen Wendelschafer-Crabb; Alexander Vortmeyer; Richard Powers; Kimberly Finnegan; Erika L F Holzbaur; Kenneth H Fischbeck; Christy L Ludlow
Journal:  Ann Neurol       Date:  2005-05       Impact factor: 10.422

2.  Morphological and functional asymmetry of the human recurrent laryngeal nerve.

Authors:  J M Prades; M D Dubois; J M Dumollard; L Tordella; J Rigail; A P Timoshenko; M Peoc'h
Journal:  Surg Radiol Anat       Date:  2012-07-11       Impact factor: 1.246

3.  Internodal segments in human laryngeal nerves.

Authors:  P M O'Reilly; M J Fitzgerald
Journal:  J Anat       Date:  1985-06       Impact factor: 2.610

4.  Evaluation of the Cortical Silent Period of the Laryngeal Motor Cortex in Healthy Individuals.

Authors:  Mo Chen; Rebekah L S Summers; George S Goding; Sharyl Samargia; Christy L Ludlow; Cecília N Prudente; Teresa J Kimberley
Journal:  Front Neurosci       Date:  2017-03-07       Impact factor: 4.677

5.  Asymmetric recurrent laryngeal nerve conduction velocities and dorsal cricoarytenoid muscle electromyographic characteristics in clinically normal horses.

Authors:  Marta Cercone; Caitlin M Hokanson; Emil Olsen; Norm G Ducharme; Lisa M Mitchell; Richard J Piercy; Jon Cheetham
Journal:  Sci Rep       Date:  2019-02-25       Impact factor: 4.379

Review 6.  Treatment for spasmodic dysphonia: limitations of current approaches.

Authors:  Christy L Ludlow
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2009-06       Impact factor: 1.814
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.